Through the looking glass: understanding non-inferiority

Through the looking glass: understanding non-inferiority

<p>Abstract</p> <p>Non-inferiority trials test whether a new product is not unacceptably worse than a product already in use. This paper introduces concepts related to non-inferiority, and discusses the regulatory views of both the European Medicines Agency and the United States Fo...

Full description

Bibliographic Details
Main Authors: Wittes Janet T, Schumi Jennifer
Format: Article
Language:English
Published: BMC 2011-05-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/12/1/106
id doaj-f64ff5b04ebd4afb81a3704ef912931d
record_format Article
spelling doaj-f64ff5b04ebd4afb81a3704ef912931d2020-11-25T00:19:55ZengBMCTrials1745-62152011-05-0112110610.1186/1745-6215-12-106Through the looking glass: understanding non-inferiorityWittes Janet TSchumi Jennifer<p>Abstract</p> <p>Non-inferiority trials test whether a new product is not unacceptably worse than a product already in use. This paper introduces concepts related to non-inferiority, and discusses the regulatory views of both the European Medicines Agency and the United States Food and Drug Administration.</p> http://www.trialsjournal.com/content/12/1/106
collection DOAJ
language English
format Article
sources DOAJ
author Wittes Janet T
Schumi Jennifer
spellingShingle Wittes Janet T
Schumi Jennifer
Through the looking glass: understanding non-inferiority
Trials
author_facet Wittes Janet T
Schumi Jennifer
author_sort Wittes Janet T
title Through the looking glass: understanding non-inferiority
title_short Through the looking glass: understanding non-inferiority
title_full Through the looking glass: understanding non-inferiority
title_fullStr Through the looking glass: understanding non-inferiority
title_full_unstemmed Through the looking glass: understanding non-inferiority
title_sort through the looking glass: understanding non-inferiority
publisher BMC
series Trials
issn 1745-6215
publishDate 2011-05-01
description <p>Abstract</p> <p>Non-inferiority trials test whether a new product is not unacceptably worse than a product already in use. This paper introduces concepts related to non-inferiority, and discusses the regulatory views of both the European Medicines Agency and the United States Food and Drug Administration.</p>
url http://www.trialsjournal.com/content/12/1/106
work_keys_str_mv AT wittesjanett throughthelookingglassunderstandingnoninferiority
AT schumijennifer throughthelookingglassunderstandingnoninferiority
_version_ 1725369752536219648

Similar Items